These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Plasma concentration of aldosterone, 18-hydroxy-deoxycorticosterone and cortisol in adrenal veins of patients with low-renin hypertension. Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E Horm Metab Res; 1977 Sep; 9(5):403-9. PubMed ID: 200537 [No Abstract] [Full Text] [Related]
3. 24 hour profile of 18-hydroxy-11-deoxycorticosterone in normal supine man: relationship with cortisol and aldosterone. Sulon J; Sparano F; Sciarra F; Giaquinto G; Genard P Clin Endocrinol (Oxf); 1978 May; 8(5):367-72. PubMed ID: 565684 [TBL] [Abstract][Full Text] [Related]
4. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension? Komiya I; Yamada T; Aizawa T; Takasu N; Niwa A; Maruyama Y; Ogawa A Cardiology; 1991; 78(2):99-110. PubMed ID: 2070375 [TBL] [Abstract][Full Text] [Related]
5. Role of 18-hydroxy-11-deoxycorticosterone and 16 alpha, 18-dihydroxy-11-deoxycorticosterone in hypertension. Melby JC; Dale SL Mayo Clin Proc; 1977 May; 52(5):317-22. PubMed ID: 870774 [TBL] [Abstract][Full Text] [Related]
6. The regulation of plasma 18-hydroxy 11-deoxycorticosterone in man. Williams GH; Braley LM; Underwood RH J Clin Invest; 1976 Jul; 58(1):221-9. PubMed ID: 180059 [TBL] [Abstract][Full Text] [Related]
7. Plasma levels of 18-hydroxy-11-deoxycorticosterone in essential hypertension. Honda M; Den K; Kanbegawa A; Ueda Y; Tsuchiya M; Izumi Y; Oguri K; Shiratsuchi T; Hatano M Endocrinol Jpn; 1978 Jun; 25(3):237-43. PubMed ID: 211025 [TBL] [Abstract][Full Text] [Related]
8. Urinary free 18-hydroxy-11-desoxycorticosterone excretion in normal and hypertensive patients. Agrin RJ; Dale SL; Holbrook M; LaRossa JT; Melby JC J Clin Endocrinol Metab; 1978 Oct; 47(4):877-84. PubMed ID: 233684 [TBL] [Abstract][Full Text] [Related]
9. [Importance of the simultaneous estimation of aldosterone, 18-hydroxy-11-deoxycorticosterone and cortisol in the adrenal veins in arterial hypertension with suppressed renin (author's transl)]. Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E Sb Lek; 1977 Jan; 79(1):1-10. PubMed ID: 841259 [No Abstract] [Full Text] [Related]
10. Simultaneous determination of plasma 11-deoxycorticosterone, 18-hydroxy-11-deoxycorticosterone, and aldosterone in man. Ojima M; Aida M; Kambegawa A Tohoku J Exp Med; 1978 Apr; 124(4):367-79. PubMed ID: 663934 [TBL] [Abstract][Full Text] [Related]
11. 18-hydroxy-11-deoxycorticosterone response to ACTH, insulin and furosemide administration in essential hypertensive patients. Tosti-Croce C; Giaquinto G; Graziosi S; Odoardi A; Sparano F; Sciarra F Horm Res; 1981; 15(1):28-36. PubMed ID: 6277757 [TBL] [Abstract][Full Text] [Related]
12. Relationship of 19-nor-deoxycorticosterone to other mineralocorticoids in low-renin hypertension. Griffing GT; Dale SL; Holbrook MM; Melby JC Hypertension; 1983; 5(3):385-9. PubMed ID: 6341221 [TBL] [Abstract][Full Text] [Related]
14. Adrenocortical hormones, ageing and mental condition: seasonal and circadian rhythms of plasma 18-hydroxy-11-deoxycorticosterone, total and free cortisol and urinary corticosteroids. Touitou Y; Sulon J; Bogdan A; Reinberg A; Sodoyez JC; Demey-Ponsart E J Endocrinol; 1983 Jan; 96(1):53-64. PubMed ID: 6822782 [TBL] [Abstract][Full Text] [Related]
15. Response of several adrenal steroids to ACTH stimulation in essential hypertension. Honda M; Nowaczynski W; Guthrie GP; Messerli FH; Tolis G; Kuchel O; Genest J J Clin Endocrinol Metab; 1977 Feb; 44(2):264-72. PubMed ID: 190252 [TBL] [Abstract][Full Text] [Related]
16. Pathogenetic aspects of hypertension in Cushing's syndrome. Tenschert W; Baumgart P; Greminger P; Vetter W; Vetter H Cardiology; 1985; 72 Suppl 1():84-90. PubMed ID: 3902234 [TBL] [Abstract][Full Text] [Related]
17. Adrenal circadian system in young and elderly human subjects: a comparative study. Touitou Y; Sulon J; Bogdan A; Touitou C; Reinberg A; Beck H; Sodoyez JC; Demey-Ponsart E; Van Cauwenberge H J Endocrinol; 1982 May; 93(2):201-10. PubMed ID: 7086322 [TBL] [Abstract][Full Text] [Related]
18. Rapid increase of mineralocorticoids after furosemide in low-renin essential hypertension: evidence for 18-hydroxycorticosterone to be a better marker than aldosterone. Witzgall H; Thayil G; Weber PC Klin Wochenschr; 1982 Aug; 60(16):847-52. PubMed ID: 6752560 [TBL] [Abstract][Full Text] [Related]
19. Mineralocorticoid secretion in essential hypertension with normal and low plasma renin activity. Messerli FH; Kuchel O; Nowaczynski W; Seth K; Honda M; Kubo S; Boucher R; Tolis G; Genest J Circulation; 1976 Mar; 53(3):406-10. PubMed ID: 1248073 [TBL] [Abstract][Full Text] [Related]
20. [Physiological regulation and clinical significance of 18-hydroxy-11-deoxycorticosterone]. Li G; Kuang AK; Ding T Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):94-7, 126. PubMed ID: 2985345 [No Abstract] [Full Text] [Related] [Next] [New Search]